A randomized phase II study of cabiralizumab (cabira) + nivolumab (vivo) ± chemotherapy (chemo) in advanced pancreatic ductal adenocarcinoma (PDAC) Meeting Abstract
| Authors: | Wang-Gillam, A.; O'Reilly, E. M.; Bendell, J. C.; Wainberg, Z. A.; Borazanci, E. H.; Bahary, N.; O'Hara, M. H.; Beatty, G. L.; Pant, S.; Cohen, D. J.; Leong, S.; Beg, M. S.; Yu, K. H.; Evans, T. R. J.; Seufferlein, T.; Okusaka, T.; Phillips, P.; Liu, X.; Perna, S. K.; Le, D. T. |
| Abstract Title: | A randomized phase II study of cabiralizumab (cabira) + nivolumab (vivo) ± chemotherapy (chemo) in advanced pancreatic ductal adenocarcinoma (PDAC) |
| Meeting Title: | 2019 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2019 Jan 17-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-02-01 |
| Language: | English |
| ACCESSION: | WOS:000489107600019 |
| DOI: | 10.1200/JCO.2019.37.4_suppl.TPS465 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS465 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
